Home Compare AMBU-B.CO vs DXCM
Stock Comparison · Industry comparison · Medical Devices

Ambu A/S vs DexCom: Which Stock Looks Stronger in 2026?

DexCom holds the cleaner structural position, with the lead spread across profitability and growth. Ambu A/S does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across profitability and growth, rather than sitting in one isolated gap. DexCom, Inc. leads by 50 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. AMBU-B.CO and DXCM share the same industry classification.

For a similarity-based comparison, see how Ambu A/S and DexCom each position within their functional peer groups in AssetNext.

Peer-Relative Score
AMBU-B.CO
Ambu A/S
19
Peer-Score
Signal qualityHigh
vs
DXCM
DexCom, Inc.
69
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: AMBU-B.CO vs DXCM Profitability 7 97 Stability 11 14 Valuation 39 69 Growth 15 83 AMBU-B.CO DXCM
Gap Ranking
#1 Profitability +90
#2 Growth +68
#3 Valuation +30
#4 Stability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AMBU-B.CO and DXCM Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AMBU-B.CODXCM Relative valuation Structural strength

DexCom, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, DexCom, Inc. ranks near the top of the group; Ambu A/S sits in the weaker half.
Growth
The same broad pattern appears on growth: DexCom, Inc. ranks near the top of the group, while Ambu A/S stays in the weaker half.
Profitability — Dominant Gap
AMBU-B.CO
7
DXCM
97
Gap+90in favour of DXCM

The profitability lead is mainly driven by a 15.1-point operating margin advantage.

What else supports the lead

Earnings growth is one contributing factor within the growth lead.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the AMBU-B.CO vs DXCM comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how AMBU-B.CO and DXCM each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.